These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23304258)

  • 21. Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach.
    Abdel-Daim MM; El-Tawil OS; Bungau SG; Atanasov AG
    Oxid Med Cell Longev; 2019; 2019():4179676. PubMed ID: 31467632
    [No Abstract]   [Full Text] [Related]  

  • 22. [Idebenone (noben) -- from theory to practice].
    Rachin AP; Averchenkova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):81-4. PubMed ID: 21666596
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxidative stress in Alzheimer's disease.
    Smith MA; Rottkamp CA; Nunomura A; Raina AK; Perry G
    Biochim Biophys Acta; 2000 Jul; 1502(1):139-44. PubMed ID: 10899439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases.
    Behl T; Kaur G; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Zengin G; Bungau SG; Munteanu MA; Brisc MC; Andronie-Cioara FL; Brisc C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress.
    Kang K; Xu P; Wang M; Chunyu J; Sun X; Ren G; Xiao W; Li D
    Biomed Pharmacother; 2020 Sep; 129():110439. PubMed ID: 32768941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats.
    Smaga I; Pomierny B; Krzyżanowska W; Pomierny-Chamioło L; Miszkiel J; Niedzielska E; Ogórka A; Filip M
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):280-7. PubMed ID: 22820675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
    J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress in cardiovascular pathologies: genetics, cellular, and molecular mechanisms and future antioxidant therapies.
    Manea A; Fortuno A; Martin-Ventura JL
    Oxid Med Cell Longev; 2012; 2012():373450. PubMed ID: 23346282
    [No Abstract]   [Full Text] [Related]  

  • 29. Nutraceutical antioxidants as novel neuroprotective agents.
    Kelsey NA; Wilkins HM; Linseman DA
    Molecules; 2010 Nov; 15(11):7792-814. PubMed ID: 21060289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.
    Danta CC; Piplani P
    Expert Opin Drug Discov; 2014 Oct; 9(10):1205-22. PubMed ID: 25056182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells.
    Hong SY; Jeong WS; Jun M
    Molecules; 2012 Sep; 17(9):10831-45. PubMed ID: 22964500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of antioxidants in the management of neurodegenerative disorders: A literature review.
    Panahi Y; Rajaee SM; Johnston TP; Sahebkar A
    J Cell Biochem; 2019 Mar; 120(3):2742-2748. PubMed ID: 29219206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of the pathophysiology of neurodegenerative disorders.
    Willner C
    Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of Melatonin in Aluminum-Related Neurodegenerative Disorders: a Review.
    Esparza JL; Gómez M; Domingo JL
    Biol Trace Elem Res; 2019 Mar; 188(1):60-67. PubMed ID: 29732485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why Have Clinical Trials of Antioxidants to Prevent Neurodegeneration Failed? - A Cellular Investigation of Novel Phenothiazine-Type Antioxidants Reveals Competing Objectives for Pharmaceutical Neuroprotection.
    Ohlow MJ; Sohre S; Granold M; Schreckenberger M; Moosmann B
    Pharm Res; 2017 Feb; 34(2):378-393. PubMed ID: 27896592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginkgo biloba and neurodegenerative disorders.
    Christen Y
    Front Biosci; 2004 Sep; 9():3091-104. PubMed ID: 15353340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conflicting effects of N-acetylcysteine on purified neurons derived from rat cortical culture.
    Sagara J; Bannai S; Shikano N; Makino N
    Neuroreport; 2010 Apr; 21(6):416-21. PubMed ID: 20838280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy.
    Hou L; Zhang L; Hong JS; Zhang D; Zhao J; Wang Q
    Antioxid Redox Signal; 2020 Aug; 33(5):374-393. PubMed ID: 31968994
    [No Abstract]   [Full Text] [Related]  

  • 39. Ingredients for functional drinks in neurodegenerative diseases: a review.
    Zafrilla P; Morillas JM; Rubio-Perez JM; Cantos Villar E
    Nat Prod Commun; 2009 May; 4(5):719-40. PubMed ID: 19445320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection against oxidative injury by a nucleic acid-based health product (Squina DNA) through enhancing mitochondrial antioxidant status and functional capacity.
    Lam PY; Chen N; Chiu PY; Leung HY; Ko KM
    J Med Food; 2012 Jul; 15(7):629-38. PubMed ID: 22612294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.